Ye, J., Zhu, W., Cui, Y., Zhang, Q., Xiong, Y., Jin, L., . . . Luo, W. (2025). Compound J27 alleviates high-fat diet-induced metabolic dysfunction-associated steatotic liver disease by targeting JNK. International Immunopharmacology, 154, N.PAG. https://doi.org/10.1016/j.intimp.2025.114570
Chicago Style (17th ed.) CitationYe, Jiaxi, et al. "Compound J27 Alleviates High-fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease by Targeting JNK." International Immunopharmacology 154 (2025): N.PAG. https://doi.org/10.1016/j.intimp.2025.114570.
MLA (9th ed.) CitationYe, Jiaxi, et al. "Compound J27 Alleviates High-fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease by Targeting JNK." International Immunopharmacology, vol. 154, 2025, p. N.PAG, https://doi.org/10.1016/j.intimp.2025.114570.